Related Experiment Video
Updated: Jul 1, 2025

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
The changing landscape of small cell lung cancer
Giordano Fabricio Cittolin-Santos1, Brendan Knapp1, Bharath Ganesh2
1Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
The incidence of small-cell lung cancer (SCLC) peaked in 1988 and has since declined. While survival rates have improved slightly, demographic shifts show an aging patient population and more women diagnosed with SCLC.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Small-cell lung cancer (SCLC) is known for its aggressive nature, characterized by rapid cell growth and early spread.
- Understanding demographic trends and patient outcomes is crucial for effective SCLC management.
Purpose of the Study:
- To analyze trends in the incidence, demographics, staging, and survival rates of SCLC.
- To provide insights into the evolving landscape of SCLC over nearly five decades.
Main Methods:
- Utilized the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database.
- Analyzed data from 1975 to 2019 using joinpoint analysis to identify trends in SCLC incidence, patient characteristics, and survival outcomes.
Main Results:
- SCLC incidence peaked in 1986 and declined by 2019, with its proportion among all lung cancers also decreasing.
- The median age at diagnosis increased, and the proportion of women diagnosed with SCLC rose significantly.
- Stage IV diagnosis became more prevalent, and while 1-year and 5-year survival rates improved, the increase was modest.
Conclusions:
- SCLC incidence has declined since its peak in the late 1980s.
- Key demographic shifts include an older patient population and a higher proportion of women diagnosed.
- Survival improvements for SCLC patients are statistically significant but clinically limited, highlighting the need for further therapeutic advancements.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment